Indicated for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.1

Stay up to date with all the latest news at Daxocox®

Is Breakthrough Pain Haunting your Canine OA Management? Free CPD recording available now

… Continue reading Is Breakthrough Pain Haunting your Canine OA Management? Free CPD recording available now

Animalcare leads the conversation on osteoarthritis breakthrough pain with free CPD event

Animalcare is raising awareness of the need to avoid osteoarthritis breakthrough pain, starting with a free virtual CPD event led by RCVS & EBVS European Veterinary Specialist in Anaesthesia & Analgesia, Matt Gurney. The webinar is the first of several communication events that will focus attention on patients owned by the estimated 80% of owners who feel that their pets with canine osteoarthritis (OA) may be suffering from off-days that can be associated with breakthrough pain

Animalcare launches Daxocox®, the first and only weekly oral NSAID

Animalcare is excited to launch Daxocox® (enflicoxib, a selective COX-2 inhibitor), the first and only weekly oral NSAID. Daxocox® not only achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs,1,2 but also helps reduce the risk of breakthrough pain.